View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/CMS | RIN: 0938-AT09 | Publication ID: Spring 2017 |
Title: ●Covered Outpatient Drug; State Definition Delay (CMS-2345-F2) | |
Abstract:
This rule finalizes the interim final rule with comment period published on November 15, 2016, that delayed the inclusion of the territories in the definition of States and United States until April 1, 2020. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Substantive, Nonsignificant |
RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 42 CFR 447 | |
Legal Authority: Pub. L. 111-148 |
Legal Deadline:
None |
|||||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: State |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Related RINs: Related to 0938-AQ41 | |
Agency Contact: Wendy Tuttle Health Insurance Specialist Department of Health and Human Services Centers for Medicare & Medicaid Services S1-01-16, Center for Medicaid and CHIP Services, MS: S2-14-26, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-8690 Email: wendy.tuttle@cms.hhs.gov |